Effect Of Cryolipolysis On Visceral Adiposity Index In Polycystic Ovarian Syndrome Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
this study will be carried to investigate the effect of cryolipolysis on visceral adiposity index in pco women randomized controlled trial
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 3, 2021
CompletedFirst Posted
Study publicly available on registry
February 9, 2021
CompletedStudy Start
First participant enrolled
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2022
CompletedFebruary 9, 2021
February 1, 2021
11 months
February 3, 2021
February 4, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Visceral adiposity index
indicator of adipose tissue distribution
3 months
Secondary Outcomes (4)
weight
up to 3 months
waist circumference
up to 3 months
high density lipoprotein
up to 3 months
serum triglyceride level
up to 3months
Study Arms (2)
low caloric diet
PLACEBO COMPARATORlow caloric diet (1200cal/day)
cryolipolysis
ACTIVE COMPARATORcryolipolysis 3 sessions one session every 6 weeks by 3max cool shaping device
Interventions
cryolipolysis sessions are applied on abdomen area each session for 40 min. each
Eligibility Criteria
You may qualify if:
- age ranges from 20-28 years, body mass index ranges 25-30 Kg/m2. They have pco syndrome .
You may not qualify if:
- Diabetic patients.
- Women with BMI\>30
- Women having circulatory dysfunction.
- Women with respiratory or cardiac disease
- liver disease.
- Skin disease .
- Previous abdominal or uterine surgery
- Physical impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo University
Cairo, 14788, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
fahema me okiel, phd
Cairo University
- STUDY CHAIR
amal mo youssef, phd
Cairo University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- ASSISTANT LECTURER
Study Record Dates
First Submitted
February 3, 2021
First Posted
February 9, 2021
Study Start
March 1, 2021
Primary Completion
January 30, 2022
Study Completion
February 28, 2022
Last Updated
February 9, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share